MONDAY, July 10, 2023 (HealthDay News) — U.S. seniors with mental health needs may not have much access to psychiatrists who could help them, new research shows. Despite an overall heightened demand for mental health services, nearly two-thirds of Medicare Advantage psychiatrist networks included less than 25% of all psychiatristsContinue Reading

THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading